BioRestorative Therapies (BRTX) Competitors $1.56 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends BRTX vs. CCM, BNR, ATIP, TOI, RNLX, PMD, MRAI, CNTG, OTRK, and BGLCShould you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Concord Medical Services (CCM), Burning Rock Biotech (BNR), ATI Physical Therapy (ATIP), Oncology Institute (TOI), Renalytix (RNLX), Psychemedics (PMD), Marpai (MRAI), Centogene (CNTG), Ontrak (OTRK), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. BioRestorative Therapies vs. Concord Medical Services Burning Rock Biotech ATI Physical Therapy Oncology Institute Renalytix Psychemedics Marpai Centogene Ontrak BioNexus Gene Lab Concord Medical Services (NYSE:CCM) and BioRestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability. Do institutionals and insiders believe in CCM or BRTX? 69.4% of BioRestorative Therapies shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 25.5% of BioRestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is CCM or BRTX more profitable? Concord Medical Services has a net margin of 0.00% compared to BioRestorative Therapies' net margin of -6,898.28%. Concord Medical Services' return on equity of 0.00% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioRestorative Therapies -6,898.28%-107.65%-88.32% Does the MarketBeat Community prefer CCM or BRTX? Concord Medical Services received 195 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 62.94% of users gave Concord Medical Services an outperform vote. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19762.94% Underperform Votes11637.06% BioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo Votes Does the media favor CCM or BRTX? In the previous week, Concord Medical Services had 3 more articles in the media than BioRestorative Therapies. MarketBeat recorded 3 mentions for Concord Medical Services and 0 mentions for BioRestorative Therapies. BioRestorative Therapies' average media sentiment score of 1.00 beat Concord Medical Services' score of 0.58 indicating that BioRestorative Therapies is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Positive BioRestorative Therapies Positive Which has stronger valuation & earnings, CCM or BRTX? BioRestorative Therapies has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$75.69M0.45-$41.93MN/AN/ABioRestorative Therapies$174.10K62.01-$14.41M-$2.04-0.76 Do analysts rate CCM or BRTX? BioRestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 1,053.85%. Given BioRestorative Therapies' higher possible upside, analysts plainly believe BioRestorative Therapies is more favorable than Concord Medical Services.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ABioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, CCM or BRTX? Concord Medical Services has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, BioRestorative Therapies has a beta of 63.02, suggesting that its stock price is 6,202% more volatile than the S&P 500. SummaryBioRestorative Therapies beats Concord Medical Services on 8 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Get BioRestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBioRestorative Therapieshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.80M$1.93B$5.40B$8.53BDividend YieldN/A8.02%5.15%4.14%P/E Ratio-0.7622.26113.7615.14Price / Sales62.015.431,483.0493.53Price / CashN/A10.9739.7134.04Price / Book0.644.244.665.01Net Income-$14.41M$69.56M$119.06M$225.46M7 Day Performance-3.70%-3.51%0.79%0.37%1 Month Performance-1.27%-11.01%5.65%3.57%1 Year Performance-13.38%-7.80%36.80%29.42% BioRestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBioRestorative Therapies4.0457 of 5 stars$1.56flat$18.00+1,053.8%-12.2%$10.80M$174,100.00-0.767Short Interest ↓Positive NewsCCMConcord Medical Services1.6687 of 5 stars$7.45-2.7%N/AN/A$32.33M$471.70M0.00970Analyst ForecastShort Interest ↓News CoverageBNRBurning Rock Biotech0.7289 of 5 stars$2.85+1.1%N/A-70.3%$29.20M$509.81M-0.591,390Gap DownHigh Trading VolumeATIPATI Physical Therapy1.6517 of 5 stars$5.79-1.7%N/A-19.3%$25.48M$699.02M-0.435,600Upcoming EarningsShort Interest ↓News CoverageTOIOncology Institute2.3103 of 5 stars$0.34+4.3%$2.50+636.8%-85.7%$25.26M$361.07M-0.43660Gap DownRNLXRenalytix1.2397 of 5 stars$0.21+5.7%$3.00+1,348.6%-79.7%$17.18M$2.29M-0.53100Gap UpPMDPsychemedicsN/A$2.32-0.4%N/A-6.5%$13.47M$20.79M-2.97140Positive NewsHigh Trading VolumeMRAIMarpaiN/A$0.64-20.0%$6.00+831.1%+76.9%$8.85M$37.15M-0.19150CNTGCentogeneN/AN/AN/AN/A$8.80M$48.54M0.00810Gap UpHigh Trading VolumeOTRKOntrak1.9959 of 5 stars$1.85+1.6%$45.00+2,332.4%-88.7%$7.80M$12.39M-0.05250Gap UpBGLCBioNexus Gene Lab0.9921 of 5 stars$0.38+1.4%N/A+3.9%$6.82M$9.18M0.0030Positive News Related Companies and Tools Related Companies Concord Medical Services Competitors Burning Rock Biotech Competitors ATI Physical Therapy Competitors Oncology Institute Competitors Renalytix Competitors Psychemedics Competitors Marpai Competitors Centogene Competitors Ontrak Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BRTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRTX Stock Alerts